Health Care & Life Sciences » Pharmaceuticals | VG Life Sciences Inc.

VG Life Sciences Inc.

VG Life Sciences Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$647.3 K
Shares Outstanding
107.88 M
Public Float
20.11 M

Profile

Address
121 Gray Avenue
Santa Barbara California 93101
United States
Employees -
Website http://www.vglifesciences.com
Updated 07/08/2019
VG Life Sciences, Inc. operates as a development stage biotechnology company, which engages on discovering and developing drug therapies for cancer, infectious disease, and inflammatory autoimmune disorders. The company is currently focused on researching two technologies namely Targeted Peptide Technology which targets the body's immune cells and seems to explain the mechanism behind some autoimmune diseases while presenting a possible solution and Metabolic Disruption Technology which can be used in combination with a variety of existing drugs and compounds to treat drug resistant cancers. The company was founded by Haig Keledjian in 1994 and is headquartered in San Marino, CA.

Financials

View All
Created with Highcharts 5.0.14VG Life Sciences Inc.Net Income. Fiscal year is January-December. All values USD Thousands.7 2407 2405 4185 4185 3955 3957 2697 2696 1896 1892010201120122013201402k4k6k8k
Created with Highcharts 5.0.14VG Life Sciences Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.5500220000201020112012201320140123456

Haig Keledjian
Chairman, President, CEO, Secretary & VP
Arthur Keledjian
Director